Generation of Induced Cardiac Progenitor Cells Via Somatic Reprogramming

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Feb 16

PMID 28199972

Citations 8

Authors

Jianyong Xu

Wei Lian

Lingyun Li

Zhong Huang

Affiliations

Soon will be listed here.

Abstract

It has been demonstrated that cardiac progenitor cells (CPCs) represent a more effective cell-based therapy for treatment of myocardial infarction. Unfortunately, their therapeutic application is limited by low yield of cell harvesting, declining quality and quantity during the ageing process, and the need for highly invasive heart biopsy. Therefore, there is an emerging interest in generating CPC-like stem cells from somatic cells via somatic reprogramming. This novel approach would provide an unlimited source of stem cells with cardiac differentiation potential. Here we would firstly discuss the different types of CPC and their importance in stem cell therapy for treatment of myocardial infarction; secondly, the necessity of generating induced CPC from somatic cells via somatic reprogramming; and finally the current progress of somatic reprogramming in cardiac cells, especially induced CPC generation.

Citing Articles

Partial Cell Fate Transitions to Promote Cardiac Regeneration.

Yang J Cells. 2024; 13(23).

PMID: 39682750 PMC: 11640292. DOI: 10.3390/cells13232002.

Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential.

Gao H, Pathan S, Dixon B, Pugazenthi A, Mathison M, Mohamed T Sci Rep. 2024; 14(1):24182.

PMID: 39406776 PMC: 11480346. DOI: 10.1038/s41598-024-73975-8.

Cardiac stem cells: Current knowledge and future prospects.

Mehanna R, Essawy M, Barkat M, Awaad A, Thabet E, Hamed H World J Stem Cells. 2022; 14(1):1-40.

PMID: 35126826 PMC: 8788183. DOI: 10.4252/wjsc.v14.i1.1.

Therapeutic effects of CXCR4 subpopulation of transgene-free induced cardiosphere-derived cells on experimental myocardial infarction.

Xu J, Wu H, Mai Z, Yi J, Wang X, Li L Cell Prolif. 2021; 54(6):e13041.

PMID: 33942933 PMC: 8168407. DOI: 10.1111/cpr.13041.

Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In Vivo Engraftment.

Jang W, Ji S, Park J, Kim Y, Kang S, Kim D Tissue Eng Regen Med. 2020; 17(3):323-333.

PMID: 32227286 PMC: 7260304. DOI: 10.1007/s13770-020-00244-w.

References

Ishigami S, Ohtsuki S, Tarui S, Ousaka D, Eitoku T, Kondo M . Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res. 2014; 116(4):653-64. DOI: 10.1161/CIRCRESAHA.116.304671. View

Hatzistergos K, Quevedo H, Oskouei B, Hu Q, Feigenbaum G, Margitich I . Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010; 107(7):913-22. PMC: 3408082. DOI: 10.1161/CIRCRESAHA.110.222703. View

Wada R, Muraoka N, Inagawa K, Yamakawa H, Miyamoto K, Sadahiro T . Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc Natl Acad Sci U S A. 2013; 110(31):12667-72. PMC: 3732928. DOI: 10.1073/pnas.1304053110. View

Mouquet F, Pfister O, Jain M, Oikonomopoulos A, Ngoy S, Summer R . Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res. 2005; 97(11):1090-2. DOI: 10.1161/01.RES.0000194330.66545.f5. View

Murry C, Soonpaa M, Reinecke H, Nakajima H, Nakajima H, Rubart M . Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004; 428(6983):664-8. DOI: 10.1038/nature02446. View

Muraoka N, Yamakawa H, Miyamoto K, Sadahiro T, Umei T, Isomi M . MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J. 2014; 33(14):1565-81. PMC: 4198052. DOI: 10.15252/embj.201387605. View

Burghoff S, Ding Z, Godecke S, Assmann A, Wirrwar A, Buchholz D . Horizontal gene transfer from human endothelial cells to rat cardiomyocytes after intracoronary transplantation. Cardiovasc Res. 2007; 77(3):534-43. DOI: 10.1093/cvr/cvm071. View

Buganim Y, Faddah D, Jaenisch R . Mechanisms and models of somatic cell reprogramming. Nat Rev Genet. 2013; 14(6):427-39. PMC: 4060150. DOI: 10.1038/nrg3473. View

Heusch G, Libby P, Gersh B, Yellon D, Bohm M, Lopaschuk G . Cardiovascular remodelling in coronary artery disease and heart failure. Lancet. 2014; 383(9932):1933-43. PMC: 4330973. DOI: 10.1016/S0140-6736(14)60107-0. View

10.

Thal M, Krishnamurthy P, Mackie A, Hoxha E, Lambers E, Verma S . Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair. Circ Res. 2012; 111(2):180-90. PMC: 3406600. DOI: 10.1161/CIRCRESAHA.112.270462. View

11.

Ellison G, Vicinanza C, Smith A, Aquila I, Leone A, Waring C . Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell. 2013; 154(4):827-42. DOI: 10.1016/j.cell.2013.07.039. View

12.

Behfar A, Crespo-Diaz R, Terzic A, Gersh B . Cell therapy for cardiac repair--lessons from clinical trials. Nat Rev Cardiol. 2014; 11(4):232-46. DOI: 10.1038/nrcardio.2014.9. View

13.

Gnecchi M, Zhang Z, Ni A, Dzau V . Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008; 103(11):1204-19. PMC: 2667788. DOI: 10.1161/CIRCRESAHA.108.176826. View

14.

Iekushi K, Seeger F, Assmus B, Zeiher A, Dimmeler S . Regulation of cardiac microRNAs by bone marrow mononuclear cell therapy in myocardial infarction. Circulation. 2012; 125(14):1765-73, S1-7. DOI: 10.1161/CIRCULATIONAHA.111.079699. View

15.

Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G . Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A. 2007; 104(45):17783-8. PMC: 2077031. DOI: 10.1073/pnas.0706406104. View

16.

Wilmut I, Beaujean N, Sousa P, Dinnyes A, King T, Paterson L . Somatic cell nuclear transfer. Nature. 2002; 419(6907):583-6. DOI: 10.1038/nature01079. View

17.

Martin-Puig S, Wang Z, Chien K . Lives of a heart cell: tracing the origins of cardiac progenitors. Cell Stem Cell. 2008; 2(4):320-31. DOI: 10.1016/j.stem.2008.03.010. View

18.

Noggle S, Fung H, Gore A, Martinez H, Satriani K, Prosser R . Human oocytes reprogram somatic cells to a pluripotent state. Nature. 2011; 478(7367):70-5. DOI: 10.1038/nature10397. View

19.

Bondue A, Lapouge G, Paulissen C, Semeraro C, Iacovino M, Kyba M . Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell. 2008; 3(1):69-84. DOI: 10.1016/j.stem.2008.06.009. View

20.

Tarui S, Ishigami S, Ousaka D, Kasahara S, Ohtsuki S, Sano S . Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial. J Thorac Cardiovasc Surg. 2015; 150(5):1198-1207, 1208.e1-2. DOI: 10.1016/j.jtcvs.2015.06.076. View